Thus, it can be concluded that miR-1275 upregulated by genistein can suppress the EMT and stemness of HCC cells by inhibiting the EIF5A2/PI3K/Akt signaling pathway. The gene discussed is AKT1; the disease is hepatocellular carcinoma.